Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
actin like 6A | 0.678 | 0.346 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actinin alpha 3 (gene/pseudogene) | 0.663 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
activin A receptor type 1C | 0.700 | 0.423 | 8.5E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
Alzheimer disease-10 | 0.743 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
Alzheimer disease 12 | 0.711 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
ADAM metallopeptidase domain 19 | 0.659 | 0.538 | 6.8E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2010 | ||||||||
|
ADAM like decysin 1 | 0.760 | 0.423 | 3.6E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ADAMTS like 4 | 0.656 | 0.577 | 2.6E-28 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adhesion G protein-coupled receptor E2 | 0.581 | 0.615 | 2.8E-28 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
adhesion G protein-coupled receptor E5 | 0.601 | 0.538 | 3.1E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2015 | 2019 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2012 | ||||||||
|
activity dependent neuroprotector homeobox | 0.561 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
adrenoceptor alpha 2B | 0.465 | 0.846 | 4.5E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adhesion regulating molecule 1 | 0.633 | 0.538 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2017 |